Bioavailability and efficacy of omeprazole given orally and by nasogastric tube

Curtis Larson, Nicholas J. Cavuto, David A. Flockhart, Richard B. Weinberg

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

We compared the bioavailability and the efficacy of omeprazole provided either as encapsulated enteric-coated granules or as enteric-coated granules delivered via a nasogastric tube in 10 healthy subjects. Omeprazole reduced mean pentagastrin-stimulated peak gastric acid secretion by 85.5% ± 23.7% when delivered orally and by 79.6% ± 32.1% when delivered by nasogastric tube; the mean plasma omeprazole concentration area under the curve (AUC) was 2.02 ± 0.79 after oral delivery and 1.74 ± 1.89 after nasogastric tube delivery. There was no significant difference in these parameters between the two routes of administration, and there was excellent intrasubject correlation between oral and nasogastric percent acid suppression and AUC. There was a close correlation between AUC and percent acid suppression at AUC values below 0.6, and complete acid suppression at AUC values above 0.6, regardless of the delivery route. We conclude that omeprazole delivered as enteric-coated granules via nasogastric tube provides equal bioavailability and gastric acid suppression as omeprazole given orally in its proprietary formulation.

Original languageEnglish (US)
Pages (from-to)475-479
Number of pages5
JournalDigestive diseases and sciences
Volume41
Issue number3
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Omeprazole
Biological Availability
Area Under Curve
Gastric Acid
Acids
Pentagastrin
Healthy Volunteers

Keywords

  • Bioavailability
  • Cytochrome P-450
  • Gastric acid secretion
  • Nasogastric tube
  • Omeprazole
  • Pentagastrin
  • Pharmacokinetics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Bioavailability and efficacy of omeprazole given orally and by nasogastric tube. / Larson, Curtis; Cavuto, Nicholas J.; Flockhart, David A.; Weinberg, Richard B.

In: Digestive diseases and sciences, Vol. 41, No. 3, 1996, p. 475-479.

Research output: Contribution to journalArticle

Larson, Curtis ; Cavuto, Nicholas J. ; Flockhart, David A. ; Weinberg, Richard B. / Bioavailability and efficacy of omeprazole given orally and by nasogastric tube. In: Digestive diseases and sciences. 1996 ; Vol. 41, No. 3. pp. 475-479.
@article{6b22179bea4c4230ab55a2d6518f6eb0,
title = "Bioavailability and efficacy of omeprazole given orally and by nasogastric tube",
abstract = "We compared the bioavailability and the efficacy of omeprazole provided either as encapsulated enteric-coated granules or as enteric-coated granules delivered via a nasogastric tube in 10 healthy subjects. Omeprazole reduced mean pentagastrin-stimulated peak gastric acid secretion by 85.5{\%} ± 23.7{\%} when delivered orally and by 79.6{\%} ± 32.1{\%} when delivered by nasogastric tube; the mean plasma omeprazole concentration area under the curve (AUC) was 2.02 ± 0.79 after oral delivery and 1.74 ± 1.89 after nasogastric tube delivery. There was no significant difference in these parameters between the two routes of administration, and there was excellent intrasubject correlation between oral and nasogastric percent acid suppression and AUC. There was a close correlation between AUC and percent acid suppression at AUC values below 0.6, and complete acid suppression at AUC values above 0.6, regardless of the delivery route. We conclude that omeprazole delivered as enteric-coated granules via nasogastric tube provides equal bioavailability and gastric acid suppression as omeprazole given orally in its proprietary formulation.",
keywords = "Bioavailability, Cytochrome P-450, Gastric acid secretion, Nasogastric tube, Omeprazole, Pentagastrin, Pharmacokinetics",
author = "Curtis Larson and Cavuto, {Nicholas J.} and Flockhart, {David A.} and Weinberg, {Richard B.}",
year = "1996",
doi = "10.1007/BF02282321",
language = "English (US)",
volume = "41",
pages = "475--479",
journal = "Digestive diseases and sciences",
issn = "0163-2116",
number = "3",

}

TY - JOUR

T1 - Bioavailability and efficacy of omeprazole given orally and by nasogastric tube

AU - Larson, Curtis

AU - Cavuto, Nicholas J.

AU - Flockhart, David A.

AU - Weinberg, Richard B.

PY - 1996

Y1 - 1996

N2 - We compared the bioavailability and the efficacy of omeprazole provided either as encapsulated enteric-coated granules or as enteric-coated granules delivered via a nasogastric tube in 10 healthy subjects. Omeprazole reduced mean pentagastrin-stimulated peak gastric acid secretion by 85.5% ± 23.7% when delivered orally and by 79.6% ± 32.1% when delivered by nasogastric tube; the mean plasma omeprazole concentration area under the curve (AUC) was 2.02 ± 0.79 after oral delivery and 1.74 ± 1.89 after nasogastric tube delivery. There was no significant difference in these parameters between the two routes of administration, and there was excellent intrasubject correlation between oral and nasogastric percent acid suppression and AUC. There was a close correlation between AUC and percent acid suppression at AUC values below 0.6, and complete acid suppression at AUC values above 0.6, regardless of the delivery route. We conclude that omeprazole delivered as enteric-coated granules via nasogastric tube provides equal bioavailability and gastric acid suppression as omeprazole given orally in its proprietary formulation.

AB - We compared the bioavailability and the efficacy of omeprazole provided either as encapsulated enteric-coated granules or as enteric-coated granules delivered via a nasogastric tube in 10 healthy subjects. Omeprazole reduced mean pentagastrin-stimulated peak gastric acid secretion by 85.5% ± 23.7% when delivered orally and by 79.6% ± 32.1% when delivered by nasogastric tube; the mean plasma omeprazole concentration area under the curve (AUC) was 2.02 ± 0.79 after oral delivery and 1.74 ± 1.89 after nasogastric tube delivery. There was no significant difference in these parameters between the two routes of administration, and there was excellent intrasubject correlation between oral and nasogastric percent acid suppression and AUC. There was a close correlation between AUC and percent acid suppression at AUC values below 0.6, and complete acid suppression at AUC values above 0.6, regardless of the delivery route. We conclude that omeprazole delivered as enteric-coated granules via nasogastric tube provides equal bioavailability and gastric acid suppression as omeprazole given orally in its proprietary formulation.

KW - Bioavailability

KW - Cytochrome P-450

KW - Gastric acid secretion

KW - Nasogastric tube

KW - Omeprazole

KW - Pentagastrin

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=0029919037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029919037&partnerID=8YFLogxK

U2 - 10.1007/BF02282321

DO - 10.1007/BF02282321

M3 - Article

VL - 41

SP - 475

EP - 479

JO - Digestive diseases and sciences

JF - Digestive diseases and sciences

SN - 0163-2116

IS - 3

ER -